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Abstract: Recent studies reflect the importance of using naturally occurring biopolymers as 
three-dimensional corneal keratocyte scaffolds and suggest that the porous structure of gelatin 
materials may play an important role in controlling nutrient uptake. In the current study, the 
authors further consider the application of carbodiimide cross-linked porous gelatin as an 
alternative to collagen for corneal stromal tissue engineering. The authors developed corneal 
keratocyte scaffolds by nanoscale modification of porous gelatin materials with chondroitin 
sulfate (CS) using carbodiimide chemistry. Scanning electron microscopy/energy dispersive 
X-ray spectroscopy and Fourier transform infrared spectroscopy showed that the amount of 
covalently incorporated polysaccharide was significantly increased when the CS concentration 
was increased from 0% to 1.25% (w/v). In addition, as demonstrated by dimethylmethylene blue 
assays, the CS content in these samples was in the range of 0.078–0.149 nmol per 10 mg scaffold. 
When compared with their counterparts without CS treatment, various CS-modified porous 
gelatin membranes exhibited higher levels of water content, light transmittance, and amount 
of permeated nutrients but possessed lower Young’s modulus and resistance against protease 
digestion. The hydrophilic and mechanical properties of scaffolds modified with 0.25% CS were 
comparable with those of native corneas. The samples from this group were biocompatible with 
the rabbit corneal keratocytes and showed enhanced proliferative and biosynthetic capacity of 
cultured cells. In summary, the authors found that the nanoscale-level modification has influence 
on the characteristics and cell-material interactions of CS-containing gelatin hydrogels. Porous 
membranes with a CS content of 0.112 ± 0.003 nmol per 10 mg scaffold may hold potential for 
use in corneal stromal tissue engineering.
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Introduction
Penetrating keratoplasty is the standard treatment for restoration of vision in patients 
with Stevens-Johnson syndrome, chemical/thermal burns, ocular cicatricial pemphig-
oid, corneal ulcers, pseudophakic bullous keratopathy, and Fuchs’ endothelial dystrophy. 
However, the donor shortage has led to the expansion of research in the field of corneal 
regenerative medicine.1 The stroma, which consists of keratocytes and extracellular 
matrix (ECM) components such as collagen and  glycosaminoglycans (GAGs), is the 
major structural element of the cornea. Therefore, collagenous   biomaterials have been 
extensively investigated for tissue engineering of corneal stroma.2–4 These studies 
reflect the importance of using naturally occurring biopolymers as three-dimensional 
corneal keratocyte scaffolds.
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Gelatin is obtained by the thermal, chemical, or physical 
denaturation of collagen. As a protein-based biomaterial, 
gelatin is inexpensive and has no antigenicity under physi-
ological conditions. Using the anterior chamber of a rabbit 
eye as a model, the authors have demonstrated the ocular 
biocompatibility of gelatin hydrogels.5 Because of their bio-
adhesiveness and biodegradability, gelatin carriers are found 
to temporarily hold the tissue-engineered corneal endothelial 
cell sheets in the proper position for graft-host integration.6,7 
More recently, the 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide hydrochloride (EDC) cross-linked porous gelatin 
discs have been designed to improve aqueous humor circu-
lation and minimize adverse biological effect.8 The results 
suggest that the porous structure of gelatin materials may play 
an important role in controlling nutrient uptake. In this study, 
the authors further consider the application of carbodiimide 
cross-linked porous gelatin as an alternative to collagen for 
corneal stromal tissue engineering.
GAG is known to possess many biological activities 
such as interaction with growth factors and regulation of 
cell proliferation and differentiation. It has been documented 
that the corneal stroma contains on average GAG 0.0103 g 
per cm3.9 A study from Liu et al10 demonstrated that the 
decrease in the refractive index of EDC cross-linked collagen 
hydrogels is presumably due to the absence of GAG chains. 
Additionally, GAGs are thought to influence corneal hydra-
tion through interactions with collagen matrices.11 Although 
GAG is able to enhance hydrodynamic characteristics, the 
water sorption may simultaneously decrease the mechani-
cal stability of biomaterial scaffolds. It is highly desirable 
to introduce the optimal amount of GAG into cross-linked 
porous gelatin membranes.
Chondroitin sulfate (CS) is a linear anionic polysac-
charide composed of repeating disaccharide units of 
D-glucuronic acid and N-acetyl-D-galactosamine. It is one 
of the two major classes of GAG side chains in the corneal 
stroma and it is attached to serine residues on the core 
  protein.12 In essence, CS has a molecular mass of 20–60 kDa 
and contains free carboxylic acid groups available for 
carbodiimide-mediated modification.13 Hence, in this study, 
to fabricate the CS-modified porous gelatin scaffolds, the 
EDC was used to activate the free carboxyl groups of CS 
molecules for subsequent reaction with the remaining free 
amino groups of cross-linked gelatin molecules. The method 
based on covalent binding of polysaccharide to gelatin may 
offer the advantage of extending the in vivo residence time 
of CS to allow for better modulation of bioactivity of cor-
neal keratocytes over that based on blending. To the authors’ 
knowledge, the influence of nanoscale modification of gelatin 
with CS on the characteristics of corneal keratocyte scaffolds 
is yet to be investigated. Various CS-modified gelatin mem-
branes were characterized by scanning electron microscopy 
(SEM), energy dispersive X-ray (EDS) and Fourier transform 
infrared (FTIR) spectroscopy, and dimethylmethylene blue 
(DMMB) assays. Then water content and light transmission 
measurements, mechanical and in vitro degradation tests, 
and glucose permeation and in vitro biocompatibility stud-
ies were performed to examine the relationship between CS 
levels and scaffold functionality. Cell-material interaction 
was also analyzed by monitoring the cell proliferation and 
morphology, as well as ECM production.
Materials and methods
Materials
Gelatin (type A, from porcine skin, 300 Bloom), chondroitin-
4-sulfate (type A, from bovine trachea), EDC, ninhydrin 
reagent, collagenase (type I Clostridium histolyticum, EC 
3.4.24.3), Ehrlich’s aldehyde reagent, and glutaraldehyde 
were purchased from Sigma-Aldrich (St Louis, MO). 
N-hydroxysuccinimide (NHS) was supplied by Acros 
Organics (Geel, Belgium). Deionized water used was puri-
fied with a Milli-Q® system (Millipore, Bedford, MA). 
DMMB was purchased from Serva Feinbiochemica GmbH 
(Heidelberg, Germany). Balanced salt solution (BSS, pH 
7.4) was obtained from Alcon Laboratories (Fort Worth, TX). 
Phosphate-buffered saline (PBS, pH 7.4) was acquired from 
Biochrom (Berlin, Germany). Dispase type II was obtained 
from Roche Diagnostics (Indianapolis, IN). Medium 199, 
gentamicin, 1:1 mixture of Dulbecco’s modified Eagle’s 
medium and Ham’s F-12 medium (DMEM/F12), trypsin-
ethylenediaminetetraacetic acid, and TRIzol® reagent were 
purchased from Gibco-BRL (Grand Island, NY). Fetal 
bovine serum (FBS) and the antibiotic/antimycotic (A/A) 
solution (penicillin 10,000 U/mL, streptomycin 10 mg/mL, 
and amphotericin B 25 µg/mL) were obtained from Biologi-
cal Industries (Kibbutz Beit Haemek, Israel). All the other 
chemicals were of reagent grade and were used as received 
without further purification.
Preparation of cross-linked porous 
gelatin scaffolds
The cross-linked porous gelatin membranes were fabricated 
according to a previously published method.8 In brief, an 
aqueous solution of 10% (w/v) gelatin was obtained by 
dissolution of gelatin powder in deionized water at 40°C. 
The resulting solution was then poured into a polystyrene 
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planar mold (5 × 5 cm2, 1.5 cm depth), subjected to freezing 
at −80°C for 24 hours, and lyophilized at −55°C for 2 days. 
All the prepared gelatin sheets were cross-linked by directly 
immersing the samples in an ethanol-water mixture (8:2, v/v; 
pH 4.75) containing EDC 50 mmol/L and NHS 10 mmol/L. 
The cross-linking reaction was allowed to proceed at 25°C 
for 1.5–96 hours, and the treated samples were washed thor-
oughly with deionized water to remove excess EDC and urea 
by-product. Using a 7 mm diameter corneal trephine device, 
the gelatin sheets were cut out to obtain porous membrane 
scaffolds (approximately 100 µm in thickness).
The ninhydrin assay was used to determine the amount 
of free amino groups of the chemically cross-linked gelatin 
samples.14 Following reaction with ninhydrin, the optical 
absorbance of the test solution was recorded with an ultra-
violet-visible spectrophotometer (Evolution 300; Thermo 
Scientific, Waltham, MA) at 570 nm, using glycine at various 
known concentrations as standard. The amount of free amino 
groups in the material before (Ci) and after (Cf) cross-linking 
is proportional to the optical absorbance of the solution. The 
extent of cross-linking of the gelatin scaffolds was calculated 
as cross-linking index (%) = ((Ci − Cf)/Ci) × 100. Results were 
averaged on five independent runs.
Modification of porous gelatin scaffolds 
with CS
After EDC/NHS cross-linking at 25°C for 12 hours, the 
porous gelatin membrane scaffolds (10 mg) were again 
immersed in an ethanol-water mixture (8:2, v/v; pH 4.75) 
containing EDC 10 mmol/L, NHS 2 mmol/L, and 0%–1.25% 
(w/v) CS. The reaction proceeded for 24 hours under gentle 
shaking. To remove ionically bound CS, the treated samples 
were further washed with sodium chloride 500 mmol/L, 
f  ollowed by washing with deionized water. The porous 
gelatin scaffolds were divided into four groups, depending 
on the amount of CS used (0%, 0.05%, 0.25%, or 1.25% 
(w/v)), and were labeled accordingly: GCS000, GCS005, 
GCS025, and GCS125.
Scaffold characterizations
The samples were observed under a scanning electron 
microscope (S-3000 N; Hitachi, Tokyo, Japan) and analyzed 
with an energy dispersive X-ray spectroscope (Oxford Instru-
ments, Concord, MA).15 Small pieces of the membrane scaf-
folds were cut off and mounted onto stubs using double-sided 
adhesive tape. The cross-section morphology of the samples 
was studied using a scanning electron microscope with an 
accelerating voltage of 20 kV . Twenty different pores were 
randomly selected, and the average pore diameters were 
calculated. Results were averaged on three independent 
runs. The elemental distribution was determined using X-ray 
elemental mapping. The solvent displacement method was 
used for porosity measurements. Each gelatin scaffold was 
first dried to a constant weight (Wi) in vacuo. The test samples 
were immersed in absolute ethanol overnight, blotted with 
tissue paper to remove excess ethanol on the surface, and 
weighed (Wf) immediately. The porosity (%) was calculated 
as ((Wf − Wi)/Vρ) × 100, where V is the volume of the hydrogel 
scaffold and ρ is the density of absolute ethanol. Results were 
averaged on five independent runs.
The FTIR spectroscopy of various samples was per-
formed using a FT-730 ATR-FTIR spectrophotometer 
(Horiba, Kyoto, Japan) according to a previously published 
method.16 The spectra were recorded between 3700 and 
900 cm−1, with a resolution of 8 cm−1. The data were analyzed 
using FTIR spectrum software (Horiba) to obtain quantita-
tive peak information. The results were the average of three 
independent experiments.
The CS content of various modified gelatin scaffolds was 
determined by DMMB assay. After hydrolysis of membranes 
with hydrogen chloride 6 N at 105°C for 6 hours, the samples 
were mixed with DMMB reagent solution (sodium chloride 
40 mmol/L; glycine 40 mmol/L ; DMMB 46 µmol/L, pH 3.0). 
The absorbance was read at 525 nm, using a spectrophotometer 
(Multiskan® Spectrum microplate; Thermo Labsystems, Van-
taa, Finland), and referenced to a standard curve of CS over 
a range of concentrations from 0.01 to 2.5 nmol/mL. All 
experiments were conducted in quadruplicate.
Water content measurements
For water content measurements, the samples were first dried 
to a constant weight (Wi) in vacuo and were then immersed in 
BSS at 34°C (physiological temperature of the cornea) with 
reciprocal shaking (50 rpm) in a thermostatically controlled 
water bath. After 4 hours, the swollen membrane scaffolds 
were weighed (Ws), and the equilibrium water content (%) 
of the test sample was defined by ((Ws − Wi)/Ws) × 100, as 
described previously.17 Results were averaged on six inde-
pendent runs.
Light transmission measurements
After equilibrium swelling was reached, each sample was 
placed in a cell in the middle of the custom-built holder. 
The optical transmittance of the membranes was measured 
using the ultraviolet-visible spectrophotometer, operating in 
a spectral range of 400–700 nm.18 During spectrometry of 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1103
Nanoscale modification of gelatin scaffolds with chondroitin sulfateInternational Journal of Nanomedicine 2012:7
scaffolds, the reference sample is the holder only, and the test 
sample consists of the holder with the membrane in place.
Mechanical tests
The uniaxial tensile tests were used to characterize the 
mechanical properties of various membrane scaffolds.19 
Each sample was immersed in BSS for 4 hours to reach 
the fully swollen state. Subsequently, wet membranes 
under pressure were cut with a suitable mold to prepare 
dumbbell-shaped specimens. The gauge length of the speci-
mens was 10 mm and the width was 5 mm. All measure-
ments were performed at 25°C and a relative humidity of 
50% using an Instron universal testing machine (Mini 44; 
Instron, Canton, MA). The crosshead speed was set at 
1 mm per minute. Young’s modulus was determined from 
load-displacement curves. Results were averaged on eight 
independent runs.
In vitro degradation tests
To measure the extent of degradation, each sample was 
first dried to a constant weight (Wi) in vacuo and was then 
immersed in 1 mL of BSS containing collagenase 12 µg 
at 34°C. Degradation medium was replaced weekly with 
fresh buffer solution containing the same concentration 
of enzyme. At predetermined time intervals, the degraded 
membranes were collected and further dried in vacuo. 
The dry weight of scaffolds after degradation (Wd) was 
determined and the percentage of weight remaining was 
calculated as (Wd/Wi) × 100. Results were averaged on five 
independent runs.
Glucose permeation studies
Glucose permeation studies were performed at 34°C using a 
horizontal glass diffusion cell (PermeGear, Inc,   Hellertown, 
PA), having two stirred chambers with sampling ports. The 
donor chamber was filled with a 50 mg/mL glucose solution 
in BSS (3 mL) and the receptor chamber was filled with 
BSS (3 mL). After immersion in BSS until equilibrium 
swelling, the membranes were placed between the two 
chambers. During the measurements, all solutions were 
stirred continuously to provide uniform solute distribution 
and to reduce the boundary layer of glucose. After 12 hours, 
the receptor chamber was sampled and analyzed using a 
glucose assay kit (Sigma-Aldrich).8 Photometric read-
ings at 540 nm were measured with a spectrophotometer 
(Thermo Scientific) and compared with a standard curve 
of known glucose concentrations. Results were averaged 
on five independent runs.
Isolation and culture of rabbit corneal 
keratocytes
Twelve adult male New Zealand white rabbits (National 
Laboratory Animal Breeding and Research Center, Taipei, 
Taiwan, Republic of China) weighing 2.5–3.0 kg were used 
for this study. All animal procedures were approved by the 
Institutional Review Board and were performed in accor-
dance with the ARVO (Association for Research in Vision 
and Ophthalmology) Statement for the Use of Animals in 
Ophthalmic and Vision Research. For the isolation of stromal 
keratocytes, each cornea was exposed to Medium 199 and 
50 µg/mL of gentamicin. Under a dissecting microscope 
(Leica, Wetzlar, Germany), Descemet’s membrane with 
the attached endothelium was aseptically stripped from the 
stroma.20 The remaining stroma with epithelium was incu-
bated in 5 mg/mL of dispase II at 4°C overnight.21 Loose 
epithelial sheets were removed, and stromal discs were cut 
into small pieces and digested using 4 mg/mL of collagenase 
I for 24 hours at 37°C. The keratocytes were mechanically 
dissociated into single cells, and a cell pellet was collected 
via centrifugation (1000 rpm, 25°C, 5 minutes). Thereafter, 
rabbit corneal keratocytes (RCKs) were resuspended and 
maintained in regular culture medium consisting of DMEM/
F12, 10% FBS, and 1% A/A solution. Cultures were incu-
bated in a humidified atmosphere of 5% carbon dioxide 
(CO2) at 37°C. The medium was changed every other day. 
Confluent cell layers were subcultured by treating with 
trypsin-ethylenediaminetetraacetic acid for 2 minutes and 
seeded at a 1:4 split ratio. Only third-passage RCKs were 
used for this study.
In vitro biocompatibility studies
The procedure for the in vitro biocompatibility evaluation 
of the membrane scaffolds conducted was adapted from the 
ISO10993-5 standard test method.22 The material samples 
were sterilized in a 70% ethanol solution overnight and 
were thoroughly rinsed in sterilized PBS. A single extract of 
the test article was prepared using regular growth medium 
containing DMEM/F12, 10% FBS, and 1% A/A solution. 
The extracts were obtained by incubation of the sterilized 
materials with culture medium at 37°C for 24 hours, with 
an extraction ratio of 0.2 g/mL. Each test extract was then 
placed onto RCK cultures with a seeding density of 5 × 104 
cells/well, and maintained at 37°C in the presence of 5% CO2 
for 48 hours. The cells in regular growth medium without 
contacting material samples served as control groups.
Cell morphology was observed by phase contrast 
microscopy (Nikon Instruments, Inc, Melville, NY). 
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P  roinflammatory cytokine interleukin-6 (IL-6) expression 
was detected at messenger RNA levels.23 Total RNA was 
isolated from cells with TRIzol reagent according to the 
manufacturer’s guidelines. Reverse transcription of the 
extracted RNA (1 µg) was performed using ImProm-II (Pro-
mega, Madison, WI) and Oligo(dT)15 Primer (Promega). The 
primers used to amplify the rabbit IL-6 complementary DNA 
(cDNA) were 5′-AAGAAAACACCAGGGTCAGCAT-3′ 
(sense) and 5′-CTTGAGGGTGGCTTCTTCATTC-3′ 
(  antisense); those used to amplify the internal control cDNA, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
were 5′-TTGCCCTCAATGACCACTTTG-3′ (sense) 
and 5′-TTACTCCTTGGAGGCCATGTG-3′ (antisense). 
  Quantitative real-time reverse transcription polymerase chain 
reaction was performed on a Light Cycler® instrument (Roche 
Diagnostics) according to the manufacturer’s instructions and 
with Light Cycler FastStart® DNA Master SYBR® Green I 
reagent (Roche Diagnostics). Each sample was determined 
in triplicate and the results for IL-6 were normalized to the 
level of GAPDH messenger RNA.
Cell culture studies
After attachment of RCKs (3.5 × 104 cells/scaffold) onto 
the sterilized membrane scaffolds, the samples were washed 
three times with PBS to remove nonattached cells. The 
cell-polymer constructs were immediately transferred to a 
new culture well, and the medium was replaced with fresh 
growth medium. After 1–5 days of incubation at 37°C, the 
proliferation of the cells was evaluated using the CellTiter 
96® AQueous Non-Radioactive Cell Proliferation Assay 
(methanethiosulfonate) (Promega), in which the methane-
thiosulfonate tetrazolium compound is bioreduced by cells 
to form a water-soluble colored formazan.24 The amount 
of colored product is proportional to the number of meta-
bolically active cells. The combined methanethiosulfonate/
phenazine methosulfate (20:1) reagent (100 µL) was added 
to each well of the 24-well plate, and incubated for 3 hours 
at 37°C in a CO2 incubator. The data of absorbance readings 
at 490 nm were measured using the Multiskan® Spectrum 
microplate spectrophotometer (Thermo Labsystems), and 
referenced to a standard curve of absorbance versus cell 
number as determined by hemacytometer. All experiments 
were carried out in quadruplicate.
After RCK cultivation on various scaffolds for 1, 3, and 
5 days, the supernatants were respectively collected for 
analyses of collagen and GAG contents. Blank experiments 
(culture medium exposed to the cell-free scaffolds) were con-
ducted simultaneously for correction of results. The amount 
of hydroxyproline, which is an amino acid marker of   collagen, 
was determined with some modifications of the protocol 
used for quantification of hydroxyproline in aqueous humor.8 
Briefly, after the addition of Ehrlich’s aldehyde reagent to 
each sample, the absorbance was read at 550 nm by using a 
spectrophotometer (Thermo Labsystems) and was compared 
with a standard calibration curve to quantify the amount of 
hydroxyproline. Colorimetric assay with DMMB reagent was 
used to determine the GAG content, as described earlier. All 
experiments were conducted in triplicate.
Additionally, the constructs prepared from 5 days’ 
cultivation of the RCKs on GCS000 and GCS025 samples 
were further processed for SEM observations.25 Evaluations 
of cell-free scaffolds were conducted simultaneously for 
  comparison. In brief, the samples were fixed with 2% glutar-
aldehyde in 0.1 mol/L of cacodylic acid buffer (pH 7.4), post 
fixed in 1% osmium tetroxide, and dehydrated in a graded 
series of ethanol solutions. The dried specimens were then 
sputter coated with gold before examination under scanning 
electron microscope.
Quantitative real-time reverse transcription polymerase 
chain reaction studies were performed according to the 
method described for the in vitro biocompatibility stud-
ies. The sequences of the primer pairs for rabbit keratocan 
were 5′-CTCACGTGGCTTTGATGTGT-3′’ (sense) and 
5′-GACCTTTGTGAGGCGATTGT-3′ (antisense); the 
primers used to amplify the rabbit biglycan cDNA were 
5′-CGGGAGCTTCATCTAGACAACA-3′ (sense) and 
5′-TCGTTGACACCCACCTTGGT-3′ (antisense). Each 
sample was determined in triplicate, and the gene expression 
results were normalized to the expression of GAPDH.
Statistics
Results were expressed as mean plus or minus standard 
  deviation. Comparative studies of means were performed 
using one-way analysis of variance, and P , 0.05 was con-
sidered statistically significant.
Results and discussion
Preparation of cross-linked porous 
gelatin scaffolds
Freeze-drying is a widely used method to prepare porous 
gelatin hydrogel scaffolds.26,27 In order to enhance the 
mechanical and degradation-resistant properties of gelatin 
materials, the porous hydrogel scaffolds were further cross-
linked with EDC/NHS (molar ratio of EDC to NHS, 5:1).18 
The cross-linking index of gelatin hydrogels as a function 
of treatment time is shown in Figure S1. After reaction 
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with cross-linkers for a short period of time (ie, 1.5 hours), 
the samples had a cross-linking index of 19.4% ± 1.2%. 
The cross-linking degrees continued to increase, reaching 
75.4% ± 1.8% by 12 hours of treatment, probably because 
of the gradual formation of new cross-links. Although the 
number of free amino groups available for cross-linking has 
been reported to be 30 per 1000, compared with carboxylic 
acid groups at 120 per 1000, the number of the consumed 
carboxylic acid groups is simply 16 per 1000 during carbo-
diimide cross-linking of collagenous biomaterials.28 In the 
present work, the plateau level was maintained even for long 
cross-linking times (ie, 96 hours), implying that the NHS-
activated carboxylic acid groups of glutamic or aspartic acid 
residues have already completely reacted with free amino 
groups of lysine residues to generate amide bonds in gelatin. 
Therefore, the remaining free amino groups of cross-linked 
gelatin molecules are subsequently available to react with 
free carboxyl groups of CS molecules.
Characterizations of CS-modified  
porous gelatin scaffolds
Previously, the authors have shown that the pore size and 
porosity of freeze-dried gelatin hydrogels can be controlled 
by the heat transfer rate on the nucleation and growth 
of ice crystals during the freezing process at different 
  temperature levels.8 The increase in freezing temperature may 
lead to the enlarged pore structure of the membranes. In this 
study, to fabricate the scaffolds with adequate pore size for 
RCK growth, the gelatin solutions were subjected to freezing 
at –80°C for 24 hours. Figure 1A shows the cross-sectional 
SEM images of various CS-modified gelatin scaffolds. In all 
groups, the samples presented a porous three-dimensional 
structure with thin pore walls. Additionally, similar pore 
size of around 50 µm and porosity of around 25% were 
found (Figures S2 and S3), indicating that the modification 
with 0%–1.25% (w/v) CS does not markedly change the 
porous structure of EDC/NHS cross-linked gelatin scaffolds. 
Since the dimension of each corneal stromal keratocyte is 
24–35 µm long and 11–14 µm wide,29 the results suggest that 
the porous gelatin scaffolds can provide sufficient space to 
support cell cultivation.
The energy dispersive X-ray microanalysis mapping tech-
nique was employed to investigate the sulfur distribution of 
the gelatin scaffolds before and after modification with CS. 
The region enclosed by a square on the SEM images shows the 
area analyzed with EDS spectra (Figure 1B). The white dots 
represent the detected sulfur element and the black area indi-
cates the absence of a specific element. Gelatin is a naturally 
occurring biopolymer that preserves a unique amino acid 
composition.30 As shown in Figure 1C, the carbon, oxygen, 
Figure 1 Scanning electron microscopy/energy dispersive X-ray spectroscopy (EDS) mapping of various porous gelatin scaffolds modified with chondroitin-4-sulfate (GCS000, 
GCS005, GCS025, and GCS125): (A) scanning electron microscopy images, (B) EDS mapping of sulfur, and (C) EDS spectrogram.
Notes: Scale bars are 50 µm; scaffold groups labeled according to chondroitin-4-sulfate concentration used (0%, 0.05%, 0.25%, or 1.25% (w/v)): GCS000, GCS005, GCS025, 
and GCS125.
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and nitrogen peaks in the EDS spectrogram were noted for all 
samples. In the GCS000 groups, the S signals were detected 
because the methionine of gelatin is a sulfur-containing 
amino acid. Moreover, in the other groups, the porous scaf-
folds had stronger sulfur peak intensities, suggesting the 
successful incorporation of CS into the gelatin materials. 
Although EDS is a semiquantitative characterization tool 
and its spectrum simply provides a measure of specific ele-
ments in the selected area, the present results demonstrate 
that after modification with CS of high concentration, more 
white dots appear (Figure 1B).
Representative spectra for the CS and various CS-  modified 
gelatin samples in the wavenumber range of 3700–900 cm−1 
are shown in Figure 2A. In the GCS000 groups, the EDC/
NHS-treated gelatin materials had several characteristic 
absorption bands at 3294 cm−1 (N–H stretching vibration), 
2927 cm−1 (C–H stretching vibration), 1633 cm−1 (amide 
I, C=O stretching vibration), 1539 cm−1 (amide II, N–H 
bending vibration), and 1228 cm−1 (amide III, N–H bend-
ing vibration). For the CS samples, the spectra exhibited 
peaks at 3350 cm−1 (–OH stretching vibration), 1030 cm−1 
(C–O–C stretching vibration attributed to the saccha-
ride structure), and 1228 cm−1 (S=O stretching vibration 
attributed to the negatively charged SO4
2− groups of CS 
molecules). In addition, the bands at 1403 and 1365 cm−1 
were due to the coupling of the C–O stretching vibration 
and O–H variable-angle vibration, indicating the existence 
of the free carboxyl group.31 Although the samples GCS005, 
GCS025, and GCS125 showed a similar pattern of spectra, 
the peak intensities were dependent on the CS concentra-
tion (  Figure 2B). In this study, the increased intensity ratios 
of A1228/A3294 and A1403/A3294 are indicative of increased CS 
signals. When compared with their counterparts treated with 
0.05% CS, the gelatin scaffolds modified with 1.25% CS 
revealed higher intensity S=O stretching bands. Despite the 
possibility that formation of amide bonds between gelatin and 
CS may involve the consumption of free carboxyl groups in 
the polysaccharide, the peak intensity at 1403 cm−1 slightly 
increased with an increase in the feed amount of CS for cova-
lent attachment to gelatin. These findings confirm the pres-
ence of varying levels of CS in the porous gelatin scaffolds 
and further support the observations shown in Figure 1.
During the carbodiimide-mediated modification of gela-
tin with CS, the formation of amide bonds between the free 
amino and carboxyl groups of the polypeptide chain may 
occur because the gelatin is an amphiphilic   polyelectrolyte. 
To avoid the undesirable protein self-cross-linking, in 
this study, the porous gelatin scaffolds were treated with 
EDC/NHS for 12 hours prior to reaction with CS for a fur-
ther 24 hours. The results of ninhydrin assays demonstrated 
that the number of free amino groups of gelatin does not 
change following repeated exposure to EDC and NHS in the 
absence of CS (data not shown). In contrast, under the same 
coupling conditions in the presence of CS, the number of free 
amino groups decreased, indicating that the NHS-activated 
carboxyl groups of mobile CS molecules are able to react 
with the remaining free amino groups of cross-linked gelatin 
molecules. The CS content of porous gelatin scaffolds as a 
function of CS concentration is shown in Figure 3. After 
modification, the samples from GCS005, GCS025, and 
GCS125 groups had the CS content of 0.078 ± 0.004, 
0.112 ± 0.003, and 0.149 ± 0.006 nmol per 10 mg scaffold, 
respectively. The values revealed significant differences 
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Figure  2  (A)  Fourier  transform  infrared  spectroscopy  spectra  of  chondroitin-
4-sulfate  (CS)  and  the  gelatin  samples  modified  with  varying  concentrations  of 
CS (0%–1.25% (w/v)); (B) the absorption peak ratios of the S=O stretching to 
N–H stretching bands (A1228/A3294) and C–O stretching to N–H stretching bands 
(A1403/A3294) for the gelatin samples modified with varying concentrations of CS 
(GCS000, GCS005, GCS025, and GCS125).
Notes: Values are mean plus or minus standard deviation (n = 3); *P , 0.05 versus 
all groups (compared only within A1228/A3294 or A1403/A3294 groups); scaffold groups 
labeled according to CS concentration used (0%, 0.05%, 0.25%, or 1.25% (w/v)): 
GCS000, GCS005, GCS025, and GCS125.
Abbreviation: A/A, absorbance/absorbance.
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between these three groups (P , 0.05). Given that the 
generation of amide bonds between gelatin and CS is affected 
by the collision frequency of these biomacromolecules, the 
higher concentration may lead to the covalent incorporation 
of larger amounts of CS into the porous gelatin scaffolds.
Water content measurements
Gelatin is known to exhibit rapid dissolution in aqueous 
environments. In this study, carbodiimide chemistry was 
applied to treat gelatin matrices to circumvent the constraint. 
After incubation in BSS at 34°C for 4 hours, the EDC/NHS 
cross-linked porous gelatin scaffolds from GCS000 groups 
had an equilibrium water content of 65.3% ± 0.8% (  Figure 4). 
It has been documented that the water content of normal 
cornea is around 76%.32 When the hydration levels of 
  cornea exceed 83%, epithelial and/or endothelial damage 
may occur.33 Hence, the scaffold material should be modi-
fied by introduction of an optimal amount of CS into the 
gelatin. The water content in the GCS025 (74.6% ± 0.9%) 
groups was significantly higher than that of the GCS005 
(68.7% ± 1.1%) groups and significantly lower than that of 
the GCS125 (84.1% ± 0.6%) groups (P , 0.05).
Light transmission measurements
The cornea is the transparent circular part of the front of the 
eyeball that covers the pupil, iris, and anterior chamber.1 
Figure 5 shows the light transmission through various scaf-
folds, in the visible light range of 400–700 nm. The sample 
GCS000 had an average transmittance of 36.1%, which was 
lower than that reported for human cornea (around 60%).34 
Teoh et al35 have demonstrated that the porous structure in 
ultra high-molecular-weight polyethylene film causes light 
scattering and reduces the light transmission. This may 
account for the poor transparency of porous gelatin mem-
branes without CS modification. In contrast, the transmit-
tance values in the GCS025 and GCS125 groups increased 
to 43.9% and 48.8%, respectively, suggesting the role of CS 
in the regulation of material optical properties. Results of the 
current study support a report by Vrana et al36 showing that 
the addition of GAG substantially improves the transparency 
of collagen films.
Mechanical tests
The mechanical properties of various CS-modified gelatin 
scaffolds are shown in Figure 6. The Young’s modulus 
was significantly lower in the GCS025 (5.3 ± 1.0 MPa) 
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groups than in the GCS005 (7.7 ± 0.6 MPa) and GCS000 
(8.5 ± 0.9 MPa) groups (P , 0.05). The authors’ 
findings suggest that the samples with a CS content 
$0.112 ± 0.003 nmol per 10 mg scaffold exhibit poor 
mechanical stability. One possible explanation is that the 
presence of absorbed water has a profound influence on 
the tensile properties of hydrophilic biomacromolecules.19 
Although the treatment of gelatin with 1.25% CS sig-
nificantly enhances the hydrophilicity and decreases the 
structural strength, the Young’s modulus of these porous 
scaffolds corresponds to the range of the measured normal 
corneal tissue values (ie, 0.3–7 MPa).37 The authors have 
also attempted to perform microscale modification of porous 
gelatin scaffolds with CS. However, when the CS content 
is around 1 µmol per 10 mg scaffold, the water content is 
93.3% ± 0.9% (far above 76%) and the Young’s modulus is 
0.21 ± 0.06 MPa (slightly below 0.3 MPa), indicating that 
the hydrophilic and mechanical properties of the samples 
are much different from those of native corneas. Therefore, 
the present study proposes nanoscale modification of gela-
tin with CS for potential use as tissue-engineered corneal 
keratocyte scaffolds.
In vitro degradation tests
Given that the formation of cross-links can increase the 
resistance against protease digestion, the in vitro deg-
radation rate of gelatin materials strongly depends on 
their cross-linking degree.16 The percentage of weight 
remaining for various CS-modified gelatin scaffolds as 
a function of incubation time is presented in Figure 7. In 
the GCS000 groups, approximately 20% of weight loss 
was observed during the period from 1 to 14 days, and the 
residual membranes slowly degraded with time. A similar 
trend was also noted for the other three groups. In par-
ticular, at each time point, the measured remaining weight 
showed a significant difference between the GCS005 and 
GCS125 groups (P , 0.05), suggesting that the incorpo-
ration of larger CS amounts may accelerate the cleavage 
of peptide bonds within the triple-helical structure of 
gelatin. As mentioned, the samples with more CS content 
had higher water content, thus possibly increasing the 
access of enzyme to the active sites of the polymer chains 
and promoting exogenous collagenolytic degradation of 
scaffold matrices.
Glucose permeation studies
The concentration of glucose permeated through various 
CS-modified gelatin scaffolds at 34°C for 12 hours is shown 
in Figure 8. The glucose concentration in the GCS000, 
GCS005, GCS025, and GCS125 groups was 828.3 ± 49.4, 
946.1 ± 55.6, 1140.0 ± 65.0, and 1341.7 ± 76.1 µmol/L, 
respectively. There were significant differences among these 
groups (P , 0.05). The present data indicate that an increase 
in the amount of permeated nutrients is observed with 
increasing CS concentration. The EDC/NHS cross-linked 
gelatin hydrogels are macromolecular networks able to absorb 
large amounts of water without dissolution. In the range 
0.1–0.001 mol/L of ionic strength, the pKa of the carboxyl 
group of CS increases from 3.5 to 5.7.38 As a result, a stronger 
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Figure 7 Time course of the percentage of weight remaining for various chondroitin-
4-sulfate-modified porous gelatin scaffolds (GCS000, GCS005, GCS025, and GCS125) 
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Notes: An asterisk indicates statistically significant differences (*P , 0.05; n = 5) 
for the mean value of weight remaining compared with value at previous time point; 
#P , 0.05 versus all groups; +P , 0.05 versus GCS025 and GCS125 groups; ^P , 0.05 
versus GCS000 and GCS005 groups; ∼P , 0.05 versus GCS000 and GCS125 groups 
(compared only within each time point group); scaffold groups labeled according 
to chondroitin-4-sulfate concentration used (0%, 0.05%, 0.25%, or 1.25% (w/v)): 
GCS000, GCS005, GCS025, and GCS125.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1109
Nanoscale modification of gelatin scaffolds with chondroitin sulfateInternational Journal of Nanomedicine 2012:7
1400
1200
1000
800
600
400
200
0
C
o
n
c
e
n
t
r
a
t
i
o
n
 
o
f
 
g
l
u
c
o
s
e
 
p
e
r
m
e
a
t
e
d
 
(
µ
m
o
l
/
L
)
GCS000 GCS005 GCS025 GCS125
*
*
*
*
Figure  8  Concentration  of  glucose  permeated  through  various  chondroitin-4-
sulfate-modified porous gelatin scaffolds (GCS000, GCS005, GCS025, and GCS125) 
at 34°C.
Notes: Values are mean plus or minus standard deviation (n = 5); *P , 0.05 versus 
all groups; scaffold groups labeled according to chondroitin-4-sulfate concentration 
used (0%, 0.05%, 0.25%, or 1.25% (w/v)): GCS000, GCS005, GCS025, and GCS125.
electrostatic repulsive force existing between carboxylate 
ions contributes to the expansion of the biopolymer network 
structure of sample GCS125, thereby detecting the higher 
glucose concentration in the receptor chamber under physi-
ological buffer conditions.
In vitro biocompatibility studies
Representative light microscopic images of RCK cultures 
photographed after 2 days are shown in Figure 9A. The 
keratocytes exposed to serum in vitro are known to exhibit 
a fibroblastic morphology. In this study, all the examined 
cells in the control groups showed this characteristic feature. 
Except for the GCS125 groups, the CS-modified gelatin 
materials of all groups demonstrated similar culture results. 
The RCKs also appeared healthy and actively proliferated. 
After the exposure to the sample GCS125, the cells are wider/
flatter and more cuboidal than the control cells.
The proinflammatory gene expression of RCKs exposed 
to various CS-modified gelatin samples for 2 days is shown 
in Figure 9B. It was found that the IL-6 expression levels 
of cells did not differ significantly between the control and 
experimental groups treated with concentrations of CS rang-
ing from 0% to 1.25%. The present results indicate that the 
incubation of RCKs with extract medium conditioned with 
the test samples has little effect on inflammation. According 
to the authors’ recent reports, the carbodiimide cross-linked 
gelatin hydrogel has excellent compatibility toward corneal 
endothelial cells,8 iris pigment epithelial cells,39 and retinal 
pigment epithelial cells.14 Moreover, GAGs are nonimmu-
nogenic and biodegradable to nontoxic oligosaccharides.40 
In this study, the RCK cultures contacting with CS-modified 
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Figure 9 (A) Phase contrast micrographs of rabbit corneal keratocyte cultures 
incubated  for  2  days  at  37°C  with  extract  medium  conditioned  with  various 
chondroitin-4-sulfate-modified porous gelatin scaffolds (control, GCS000, GCS005, 
GCS025, and GCS125); (B) gene expression of interleukin-6 (IL-6) in rabbit corneal 
keratocytes incubated with extract medium conditioned with various chondroitin-
4-sulfate-modified porous gelatin scaffolds for 2 days, measured by real-time reverse 
transcription polymerase chain reaction.
Notes: Scale bars, 100 µm; glyceraldehyde-3-phosphate dehydrogenase was used 
for normalization; data in the experimental groups are percentages relative to that of 
control groups (without materials); values are mean plus or minus standard deviation 
(n = 3); scaffold groups labeled according to chondroitin-4-sulfate concentration 
used (0%, 0.05%, 0.25%, or 1.25% (w/v)): GCS000, GCS005, GCS025, and GCS125.
Abbreviation: mRNA, messenger RNA.
gelatin materials does not upregulate their expression of IL-6, 
suggesting good in vitro biocompatibility of the scaffolds.
Cell culture studies
The results of quantitative analysis for RCK proliferation 
within various scaffolds are shown in Figure 10. After 1 day 
of culture, the total cell number in GCS000, GCS005, and 
GCS025 groups reached about 5 × 104, compared with the ini-
tial adherent cell number (ie, 3.5 × 104). It has been reported 
that the doubling time for RCKs is 18 hours.41 In the current 
study, the cultured cells from porous three-dimensional 
scaffolds displayed a slower proliferation rate. For all 
the CS-modified gelatin samples, the cell proliferation 
was significantly increased in a time-dependent manner 
(P , 0.05). Both the gelatin membranes from GCS000 
and GCS005 groups did not affect cell proliferation at 
each time point. During the period of 5 days, the total cell 
number in GCS000 groups ranged from 5 × 104 to 6 × 104. 
However, the RCKs on the scaffolds modified with higher 
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CS into the porous gelatin scaffolds can effectively expand 
the biosynthetic capacity of cultured RCKs. In addition to 
the measurement of the collagen and GAGs in the medium 
supernatants, the ECM production of RCKs was examined 
by the direct observation of the cell-biopolymer constructs 
after 5 days of cultivation (Figure 12A and B). SEM images 
showed that the cells of the GCS000 groups synthesized 
and deposited their own ECM components. In contrast, the 
cultures of the GCS025 groups had more abundant ECM. The 
cell-free scaffolds from both groups did not contain newly 
deposited ECM (Figure 12C and D). It has been documented 
that the biochemical composition of the biomaterial scaf-
folds plays an important role in the regulation of metabolic 
parameters of the cells.45 Meier and Hay46 reported that the 
CS proteoglycan had a stimulatory effect on GAG production 
by corneal epithelial cells.46 A study from van Susante et al47 
showed that the collagen-CS scaffold contained significantly 
more newly synthesized GAGs than in the absence of CS after 
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Figure  10  Total  cell  number  on  various  chondroitin-4-sulfate-modified  porous 
gelatin scaffolds (GCS000, GCS005, GCS025, and GCS125). after rabbit corneal 
keratocyte seeding for 1, 3, and 5 days (d1, d3, and d5, respectively).
Notes: An asterisk indicates statistically significant differences (*P , 0.05; n = 4) 
for the mean value of total cell number compared with value at previous time 
point; #P , 0.05 versus all groups; +P , 0.05 versus GCS025 and GCS125 groups 
(compared only within each time point group); scaffold groups labeled according 
to chondroitin-4-sulfate concentration used (0%, 0.05%, 0.25%, or 1.25% (w/v)): 
GCS000, GCS005, GCS025, and GCS125.
CS concentration (ie, GCS025 and GCS125 groups) showed 
significantly higher cell numbers (P , 0.05). Investigators 
have performed studies on the biological effects of CS, but 
the results are inconsistent. Ida et al42 demonstrated that the 
epidermal growth factor–mediated proliferation of neural 
stem/progenitor cells was not stimulated by CS. In contrast, 
Westergren-Thorsson et al43 reported that while the l-iduronic 
acid–containing galactosaminoglycans such as dermatan sul-
fate could inhibit the human lung fibroblast proliferation in 
vitro, the galactosaminoglycan not containing l-iduronic acid 
(ie, CS) effectively stimulated the proliferation of these cells. 
Zou et al44 also demonstrated that continuous supplementa-
tion of the culture medium with CS led to a dose-dependent 
increase in the number of palatal fibroblasts after a 7-day 
incubation period. The results of the current study indicate 
that the gelatin materials from GCS025 and GCS125 groups 
can markedly enhance the proliferative capacity of RCKs.
The total collagen and GAG contents after RCK growth 
within various scaffolds over the 5-day culture are shown 
in Figure 11 (A and B, respectively). The level of ECM 
secretion was elevated in the culture medium with increas-
ing incubation time. At day 5, the amount of total col-
lagen in the GCS000 groups was 13.5 ± 0.9 µg/106 cells, 
which was significantly lower than those of the GCS005 
(20.7 ± 1.2 µg/106 cells), GCS025 (28.2 ± 1.5 µg/106 cells), 
and GCS125 (34.6 ± 1.3 µg/106 cells) groups (P , 0.05). 
A similar trend was found for the effect of material com-
position on the variation in GAG secretion. These findings 
suggest that the covalent incorporation of larger amounts of 
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Figure 11 Extracellular matrix production capacity of rabbit corneal keratocytes at 
days 1, 3, and 5 (d1, d3, and d5, respectively) after plating on various chondroitin-4-
sulfate-modified porous gelatin scaffolds (GCS000, GCS005, GCS025, and GCS125): 
(A) collagen content and (B) glycosaminoglycan (GAG) content.
Notes: An asterisk indicates statistically significant differences (*P , 0.05; n = 3) for 
the mean value of extracellular matrix content compared with value at previous time 
point; #P , 0.05 versus all groups (compared only within each time point group); 
scaffold groups labeled according to chondroitin-4-sulfate concentration used (0%, 
0.05%, 0.25%, or 1.25% (w/v)): GCS000, GCS005, GCS025, and GCS125.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1111
Nanoscale modification of gelatin scaffolds with chondroitin sulfateInternational Journal of Nanomedicine 2012:7
14 days of chondrocyte culture. Results of the present study 
are compatible with these earlier observations and indicate 
that the differences in the CS content of porous gelatin scaf-
folds may have a profound influence on the ECM production 
capacity of RCKs.
Figure 12E shows the gene expression profiles for two 
phenotypic markers (keratocan and biglycan). The detected 
expression level for each gene in the tissue culture poly-
styrene groups was defined as 100%. After cultivation for 
5 days, the RCKs on GCS025 samples showed significantly 
lower keratocan levels and higher biglycan levels than those 
of GCS000 groups (P , 0.05), indicating that the cell phe-
notype is not adequately maintained by the incorporation of 
CS into the gelatin materials. Vrana et al48 have previously 
reported the development of a reconstructed cornea from 
collagen-CS foams and human cell cultures. The results of 
their study indicate that even though the keratocytes lose 
a phenotypic marker, these cells do not differentiate into 
myofibroblasts during culture within the foams.
Conclusion
Three-dimensional biomaterial scaffolds have been 
designed to provide temporary support for cell growth. In 
this study, nanoscale modification of gelatin with CS was 
performed to control characteristics in tissue-engineered 
corneal keratocyte scaffolds. When compared with their 
counterparts without CS modification, the porous gelatin 
membranes treated with 0.05%–1.25% CS had higher 
levels of water content, light transmittance, and amount 
of permeated nutrients, but had lower Young’s modulus 
and resistance against protease digestion. The hydrophilic 
and mechanical properties of GCS025 samples were 
comparable with those of native corneas. Additionally, 
the scaffolds modified with 0.25% CS exhibited excellent 
compatibility toward RCKs and demonstrated enhanced 
proliferative and biosynthetic capacity of cultured cells. 
The findings suggest that the gelatin materials with the 
CS content of 0.112 ± 0.003 nmol per 10 mg scaffold 
may hold potential for use in corneal stromal tissue engi-
neering. The validity of the CS-modified porous gelatin 
scaffolds requires further biological testing, which is 
currently underway.
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Figure S1 Cross-linking index of porous gelatin scaffolds treated with 1-ethyl-3-
(3-dimethyl aminopropyl) carbodiimide hydrochloride/N-hydroxysuccinimide as a 
function of cross-linking time.
Notes: An asterisk indicates statistically significant differences (*P , 0.05; n = 5) for the 
mean value of cross-linking index compared with the value at the previous time point.
Abbreviations: EDC, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride; 
NHS, N-hydroxysuccinimide. 
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Figure S2 Pore size of various porous gelatin scaffolds modified with chondroitin-
4-sulfate.
Notes: Values are mean plus or minus standard deviation (n = 3); scaffold groups 
labeled according to chondroitin-4-sulfate concentration used (0%, 0.05%, 0.25%, or 
1.25% (w/v)): GCS000, GCS005, GCS025, and GCS125.
Abbreviation: CS, chondroitin-4-sulfate. 
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Figure S3 Porosity of various porous gelatin scaffolds modified with chondroitin-
4-sulfate.
Notes: Values are mean plus or minus standard deviation (n = 5); scaffold groups 
labeled according to chondroitin-4-sulfate concentration used (0%, 0.05%, 0.25%, or 
1.25% (w/v)): GCS000, GCS005, GCS025, and GCS125.
Abbreviation: CS, chondroitin-4-sulfate.
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